The effect of Rituximab on patients with follicular and mantle-cell lymphoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/11/suppl_1/S123/7724480/11-suppl_1-S123.pdf
Reference10 articles.
1. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin’s lymphoma;Piro;Ann Oncol,1999
2. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma;Maloney;Blood,1997
3. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma;Berinstein;Ann Oncol,1998
4. Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab) in relapsed B-cell lymphoma;Tobinai;Ann Oncol,1998
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deregulated transcription factors in the emerging cancer hallmarks;Seminars in Cancer Biology;2024-01
2. Nanomedicine Based Therapies Against Cancer Stem Cells;Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective;2023-12-27
3. CAR T-Cell therapy for the management of mantle cell lymphoma;Molecular Cancer;2023-03-31
4. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance;Biomarkers;2023-01-02
5. Cancer stem cell plasticity and its implications in the development of new clinical approaches for oral squamous cell carcinoma;Biochemical Pharmacology;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3